Developmental toxicity of remdesivir, an <scp>anti‐COVID</scp> ‐19 drug, is implicated by in vitro assays using morphogenetic embryoid bodies of mouse and human pluripotent stem cells-Reference-Cited by-同舟云学术

Developmental toxicity of remdesivir, an anti‐COVID ‐19 drug, is implicated by in vitro assays using morphogenetic embryoid bodies of mouse and human pluripotent stem cells

Published:2022-11-08 Issue:2 Volume:115 Page:224-239
ISSN:2472-1727
Container-title:Birth Defects Research
language:en
Short-container-title:Birth Defects Research

Author:

Kirkwood‐Johnson Lauren¹,Marikawa Yusuke¹^ORCID

Affiliation:

1. Developmental and Reproductive Biology Graduate Program, Institute for Biogenesis Research, Department of Anatomy, Biochemistry and Physiology John A. Burns School of Medicine, University of Hawaii at Manoa Honolulu Hawaii USA

Funder

Alternatives Research and Development Foundation

National Institute of Child Health and Human Development

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Health, Toxicology and Mutagenesis,Developmental Biology,Toxicology,Embryology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bdr2.2111

Reference63 articles.

1. Akinci E. Cha M. Lin L. Yeo G. Hamilton M. C. Donahue C. J. …Sherwood R. I.(2020).Elucidation of remdesivir cytotoxicity pathways through genome‐wide CRISPR‐Cas9 screening and transcriptomics. bioRxiv [Preprint]. Aug 28:2020.08.27.270819. doi:https://doi.org/10.1101/2020.08.27.270819.